A new study suggests that an older GLP-1 drug may help protect the brains of people with early Alzheimers disease, supporting the case for further research on the class of medications originally developed for obesity and diabetes in neurological diseases
Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association
Return Policy Guaranteed 7-Day Return Policy For details about return shipping options, please visit - Konga Return Policy Warranty Warranty information unavailable for this item
Once promoted as a fat burner and endurance enhancer, the supplement L-carnitine has fallen out of favour in recent years
